ADITYA SHARMA: Open Payments
NPI 1659410322 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,457 in 113 payments from 24 companies in 2025. Trend: 2023 $2,677 · 2024 $3,136 · 2025 $2,457
Food & beverage: $2,457
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $336 |
| Corium, LLC | 10 | $272 |
| Shockwave Medical, Inc | 2 | $247 |
| ABBVIE INC. | 19 | $196 |
| Teva Pharmaceuticals USA, Inc. | 8 | $189 |
| Lundbeck LLC | 11 | $179 |
| Neurocrine BioSciences, Inc. | 5 | $175 |
| Vanda Pharmaceuticals Inc. | 5 | $128 |
| Tris Pharma Inc | 5 | $108 |
| Axsome Therapeutics, Inc. | 5 | $88 |
Products named: CAPLYTA, Azstarys, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR, FANAPT.
Industry payments across TX — which companies pay providers there.
